Excess ROS generation, particularly in CKD patients due to mitochondrial dysfunction, impairs NO bioavailability and activates pro-inflammatory signaling such as NF-κB, fueling a self-sustaining loop of vascular injury [36,37,38]. The gene discussed is NFKB1; the disease is chronic kidney disease.